Semiconductors
Compare Stocks
4 / 10Stock Comparison
RMBS vs SLAB vs FORM vs AMBA
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
RMBS vs SLAB vs FORM vs AMBA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $13.69B | $7.17B | $11.28B | $3.20B |
| Revenue (TTM) | $721M | $785M | $840M | $374M |
| Net Income (TTM) | $230M | $-65M | $68M | $-80M |
| Gross Margin | 77.0% | 58.2% | 42.1% | 59.8% |
| Operating Margin | 35.9% | -9.0% | 12.7% | -23.6% |
| Forward P/E | 42.9x | 80.4x | 66.5x | 95.4x |
| Total Debt | $44M | $0.00 | $45M | $5M |
| Cash & Equiv. | $183M | $364M | $103M | $145M |
RMBS vs SLAB vs FORM vs AMBA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Rambus Inc. (RMBS) | 100 | 814.7 | +714.7% |
| Silicon Laboratorie… (SLAB) | 100 | 232.4 | +132.4% |
| FormFactor, Inc. (FORM) | 100 | 540.0 | +440.0% |
| Ambarella, Inc. (AMBA) | 100 | 130.9 | +30.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RMBS vs SLAB vs FORM vs AMBA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RMBS carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (42.9x vs 95.4x)
- 31.9% margin vs AMBA's -21.3%
- 15.5% ROA vs AMBA's -10.6%, ROIC 17.1% vs -22.5%
SLAB is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- beta 1.25
- Rev growth 34.3%, EPS growth 66.6%, 3Y rev CAGR -8.5%
- Lower volatility, beta 1.25, current ratio 4.69x
- Beta 1.25, current ratio 4.69x
FORM is the clearest fit if your priority is long-term compounding.
- 19.5% 10Y total return vs RMBS's 10.1%
- +387.8% vs AMBA's +45.5%
AMBA lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 34.3% revenue growth vs FORM's 2.8% | |
| Value | Lower P/E (42.9x vs 95.4x) | |
| Quality / Margins | 31.9% margin vs AMBA's -21.3% | |
| Stability / Safety | Beta 1.25 vs RMBS's 3.00 | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +387.8% vs AMBA's +45.5% | |
| Efficiency (ROA) | 15.5% ROA vs AMBA's -10.6%, ROIC 17.1% vs -22.5% |
RMBS vs SLAB vs FORM vs AMBA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
RMBS vs SLAB vs FORM vs AMBA — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
RMBS leads in 3 of 6 categories
FORM leads 1 • SLAB leads 1 • AMBA leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
RMBS leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
FORM is the larger business by revenue, generating $840M annually — 2.2x AMBA's $374M. RMBS is the more profitable business, keeping 31.9% of every revenue dollar as net income compared to AMBA's -21.3%. On growth, FORM holds the edge at +32.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $721M | $785M | $840M | $374M |
| EBITDAEarnings before interest/tax | $288M | -$32M | $152M | -$72M |
| Net IncomeAfter-tax profit | $230M | -$65M | $68M | -$80M |
| Free Cash FlowCash after capex | $335M | $66M | -$5M | $76M |
| Gross MarginGross profit ÷ Revenue | +77.0% | +58.2% | +42.1% | +59.8% |
| Operating MarginEBIT ÷ Revenue | +35.9% | -9.0% | +12.7% | -23.6% |
| Net MarginNet income ÷ Revenue | +31.9% | -8.3% | +8.1% | -21.3% |
| FCF MarginFCF ÷ Revenue | +46.5% | +8.4% | -0.6% | +20.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.1% | +25.2% | +32.0% | +31.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -1.8% | +88.8% | +2.2% | +39.7% |
Valuation Metrics
RMBS leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 60.0x trailing earnings, RMBS trades at a 71% valuation discount to FORM's 209.7x P/E. On an enterprise value basis, RMBS's 46.6x EV/EBITDA is more attractive than FORM's 100.9x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $13.7B | $7.2B | $11.3B | $3.2B |
| Enterprise ValueMkt cap + debt − cash | $13.6B | $6.8B | $11.2B | $3.1B |
| Trailing P/EPrice ÷ TTM EPS | 60.00x | -109.92x | 209.68x | -26.15x |
| Forward P/EPrice ÷ next-FY EPS est. | 42.88x | 80.41x | 66.48x | 95.39x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 46.57x | — | 100.94x | — |
| Price / SalesMarket cap ÷ Revenue | 19.35x | 9.14x | 14.37x | 11.22x |
| Price / BookPrice ÷ Book value/share | 10.18x | 6.51x | 10.94x | 5.46x |
| Price / FCFMarket cap ÷ FCF | 41.10x | 109.03x | 960.69x | 136.31x |
Profitability & Efficiency
RMBS leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
RMBS delivers a 17.4% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-13 for AMBA. AMBA carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to FORM's 0.04x. On the Piotroski fundamental quality scale (0–9), RMBS scores 6/9 vs FORM's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +17.4% | -5.9% | +6.7% | -13.5% |
| ROA (TTM)Return on assets | +15.5% | -5.1% | +5.6% | -10.6% |
| ROICReturn on invested capital | +17.1% | -6.9% | +5.4% | -22.5% |
| ROCEReturn on capital employed | +19.5% | -6.3% | +6.1% | -22.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.03x | — | 0.04x | 0.01x |
| Net DebtTotal debt minus cash | -$139M | -$364M | -$58M | -$139M |
| Cash & Equiv.Liquid assets | $183M | $364M | $103M | $145M |
| Total DebtShort + long-term debt | $44M | $0 | $45M | $5M |
| Interest CoverageEBIT ÷ Interest expense | 217.32x | -58.63x | 252.69x | — |
Total Returns (Dividends Reinvested)
FORM leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RMBS five years ago would be worth $65,393 today (with dividends reinvested), compared to $8,015 for AMBA. Over the past 12 months, FORM leads with a +387.8% total return vs AMBA's +45.5%. The 3-year compound annual growth rate (CAGR) favors FORM at 72.9% vs AMBA's 3.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +27.5% | +65.0% | +144.4% | -1.2% |
| 1-Year ReturnPast 12 months | +148.9% | +100.3% | +387.8% | +45.5% |
| 3-Year ReturnCumulative with dividends | +161.1% | +59.0% | +417.3% | +10.8% |
| 5-Year ReturnCumulative with dividends | +553.9% | +61.0% | +273.9% | -19.8% |
| 10-Year ReturnCumulative with dividends | +1011.5% | +375.0% | +1952.2% | +94.1% |
| CAGR (3Y)Annualised 3-year return | +37.7% | +16.7% | +72.9% | +3.5% |
Risk & Volatility
SLAB leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SLAB is the less volatile stock with a 1.25 beta — it tends to amplify market swings less than RMBS's 3.00 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SLAB currently trades 99.5% from its 52-week high vs AMBA's 76.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.00x | 1.25x | 2.02x | 2.53x |
| 52-Week HighHighest price in past year | $161.80 | $218.66 | $159.09 | $96.69 |
| 52-Week LowLowest price in past year | $49.61 | $106.01 | $26.08 | $48.30 |
| % of 52W HighCurrent price vs 52-week peak | +78.2% | +99.5% | +90.9% | +76.8% |
| RSI (14)Momentum oscillator 0–100 | 58.3 | 66.1 | 66.5 | 78.9 |
| Avg Volume (50D)Average daily shares traded | 2.2M | 465K | 1.6M | 875K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: RMBS as "Buy", SLAB as "Buy", FORM as "Hold", AMBA as "Buy". Consensus price targets imply 32.4% upside for AMBA (target: $98) vs -14.7% for FORM (target: $123).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $135.67 | $211.60 | $123.38 | $98.33 |
| # AnalystsCovering analysts | 14 | 37 | 19 | 36 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% | +0.2% | 0.0% |
RMBS leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). FORM leads in 1 (Total Returns).
RMBS vs SLAB vs FORM vs AMBA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is RMBS or SLAB or FORM or AMBA a better buy right now?
For growth investors, Silicon Laboratories Inc.
(SLAB) is the stronger pick with 34. 3% revenue growth year-over-year, versus 2. 8% for FormFactor, Inc. (FORM). Rambus Inc. (RMBS) offers the better valuation at 60. 0x trailing P/E (42. 9x forward), making it the more compelling value choice. Analysts rate Rambus Inc. (RMBS) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RMBS or SLAB or FORM or AMBA?
On trailing P/E, Rambus Inc.
(RMBS) is the cheapest at 60. 0x versus FormFactor, Inc. at 209. 7x. On forward P/E, Rambus Inc. is actually cheaper at 42. 9x.
03Which is the better long-term investment — RMBS or SLAB or FORM or AMBA?
Over the past 5 years, Rambus Inc.
(RMBS) delivered a total return of +553. 9%, compared to -19. 8% for Ambarella, Inc. (AMBA). Over 10 years, the gap is even starker: FORM returned +1952% versus AMBA's +94. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RMBS or SLAB or FORM or AMBA?
By beta (market sensitivity over 5 years), Silicon Laboratories Inc.
(SLAB) is the lower-risk stock at 1. 25β versus Rambus Inc. 's 3. 00β — meaning RMBS is approximately 140% more volatile than SLAB relative to the S&P 500. On balance sheet safety, Ambarella, Inc. (AMBA) carries a lower debt/equity ratio of 1% versus 4% for FormFactor, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — RMBS or SLAB or FORM or AMBA?
By revenue growth (latest reported year), Silicon Laboratories Inc.
(SLAB) is pulling ahead at 34. 3% versus 2. 8% for FormFactor, Inc. (FORM). On earnings-per-share growth, the picture is similar: Silicon Laboratories Inc. grew EPS 66. 6% year-over-year, compared to -22. 5% for FormFactor, Inc.. Over a 3-year CAGR, RMBS leads at 15. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RMBS or SLAB or FORM or AMBA?
Rambus Inc.
(RMBS) is the more profitable company, earning 32. 6% net margin versus -41. 1% for Ambarella, Inc. — meaning it keeps 32. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RMBS leads at 36. 8% versus -44. 4% for AMBA. At the gross margin level — before operating expenses — RMBS leads at 76. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RMBS or SLAB or FORM or AMBA more undervalued right now?
On forward earnings alone, Rambus Inc.
(RMBS) trades at 42. 9x forward P/E versus 95. 4x for Ambarella, Inc. — 52. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMBA: 32. 4% to $98. 33.
08Which pays a better dividend — RMBS or SLAB or FORM or AMBA?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is RMBS or SLAB or FORM or AMBA better for a retirement portfolio?
For long-horizon retirement investors, FormFactor, Inc.
(FORM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1952% 10Y return). Ambarella, Inc. (AMBA) carries a higher beta of 2. 53 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FORM: +1952%, AMBA: +94. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RMBS and SLAB and FORM and AMBA?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: RMBS is a mid-cap high-growth stock; SLAB is a small-cap high-growth stock; FORM is a mid-cap quality compounder stock; AMBA is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.